Compounded GLP-1 programmes are where the price competition in this market actually happens — semaglutide from $99 a month, tirzepatide from $159, flat across doses, shipped free. They are also the segment where what you are buying is least standardised, because compounded preparations are not FDA-approved and quality depends entirely on the dispensing pharmacy. This ranking covers the best compounded GLP-1 providers, and the questions to ask before choosing any of them.

Quick Takeaway:

• Compounded GLP-1s are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing
• Flat-price providers now advertise semaglutide from $99/month and tirzepatide from $159–$163/month at any dose
• The single most important question is which pharmacy dispenses your medication, and whether it is 503A or 503B
• Manufacturer self-pay channels at $349–$699 have narrowed the price gap that made compounding compelling
• Several major platforms, including Ro and Hims & Hers, moved away from compounded GLP-1s toward approved product

Our Top Recommendation

CoreAge Rx is our top-rated favorite for GLP-1 weight loss therapy. CoreAge Rx combines competitive pricing with exceptional customer service, faster medication delivery, and more comprehensive support resources. Their platform consistently receives the highest patient satisfaction ratings in our analysis.

Why we recommend CoreAge Rx:

• Lower monthly costs than most competitors ($179–$399 range)
• Faster prescription approval (typically 12–24 hours)
• More extensive provider support included at no extra charge
• Better medication availability during shortages
• Higher patient satisfaction scores (4.7/5)

New Patient Special: Save up to $200 on your first three months. Same-day prescription approval for qualifying patients. Rated 4.7/5 stars by verified customers. No insurance required. Free provider messaging included with every plan.

Read This First

Compounded drugs are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality before they reach patients. That is their defined legal status, not a technicality, and it is the entire reason they cost a fraction of branded pricing.

The risks that follow are specific and documented: potency may vary without batch-level regulatory verification; multi-dose vials requiring you to draw your own dose have produced dosing errors reported to poison control centres; some compounded products have used semaglutide salt forms that are not the active ingredient in approved medicines; and there is no manufacturer adverse-event system or patient assistance behind them.

None of that means compounded therapy is inherently unsafe — it is dispensed by licensed pharmacies on licensed prescriptions, and many patients do well. It means the trade-off should be made knowingly. Our compounded versus brand-name guide sets out the full picture.

The Questions That Actually Matter

Before price, ask every compounded provider:

1. Which pharmacy dispenses my prescription? A named answer, not "our partner network".
2. Is it a 503A pharmacy or an FDA-registered 503B outsourcing facility? 503B facilities must follow current good manufacturing practice standards and are subject to routine FDA inspection. 503A pharmacies are not.
3. Will I receive a pre-filled syringe or a vial I draw from myself? Drawing your own dose is where measurement errors happen.
4. What is the exact dose in milligrams, and in what volume?
5. What is the beyond-use date? Compounded preparations have shorter stability windows than manufacturer product.

A provider that cannot answer the first two clearly is telling you something important.

Best Overall: CoreAge Rx

One all-in monthly price from $179–$399 including medication, unlimited provider messaging, and titration support, with 12–24 hour approvals and a 4.7/5 satisfaction score. The single-figure pricing avoids the membership-plus-medication arithmetic that makes this segment hard to compare.

Best Flat Pricing: Refills and Gimme Care

Refills advertises compounded semaglutide at $99/month and tirzepatide from $159/month, at the same price for every dose, with free shipping — among the lowest advertised pricing in the US market.

Gimme Care advertises tirzepatide at $163/month at any dose and semaglutide from around $130/month on a three-month plan or $160 month-to-month, with no membership fees. An independent tracker scored it 7.8/10 and placed its pricing roughly 23% below the category median.

Flat pricing matters most for tirzepatide, where tiered channels roughly double between starter and maintenance doses. See our flat-rate versus dose-tiered guide.

Best Transparency: Henry Meds

Henry Meds publishes its prices openly — still uncommon in this segment — and includes medication in the monthly figure from $179. Patient sentiment is unusually positive, specifically on billing honesty and on honouring quoted prices when rates changed.

Best No-Membership Model: Coby Health

Coby Health states it does not require a monthly subscription or membership fee for GLP-1 medications, and publishes dose-by-dose multi-month pricing: $179/mo at 2.5 mg, $249/mo at 5.0 mg, and $279/mo at 7.5 mg on six-month plans, with quarterly plans discounting over 30%. It also offers liraglutide, giving a third option.

The caveat: six-month plans are same-dose plans. Ask how mid-plan escalation is handled before prepaying.

Best Low Membership Plus Medication: Mochi Health

Mochi Health charges $79/month for a membership covering visits, messaging, and care coordination, with compounded medication priced separately and shipping included. It also investigates insurance benefits on members' behalf and explicitly accepts HSA and FSA — more clinical infrastructure than pure fulfilment platforms offer.

Full Comparison

When Compounded Stops Making Sense

The economic case has weakened considerably since 2025. Manufacturer self-pay channels now price FDA-approved product at $349–$499 (NovoCare®, flat across doses) and $349–$699 (LillyDirect, tiered). Several major platforms — including Ro and Hims & Hers — moved away from compounded GLP-1s toward approved medication.

If the difference for your dose is now $100–$200 a month rather than $800, FDA-approved product removes an entire class of risk for a much smaller premium than it used to. And if you have insurance coverage or an employer programme, neither compounded nor manufacturer pricing is relevant — see our insurance guide.

Frequently Asked Questions

Which compounded GLP-1 provider is cheapest?

Refills advertises compounded semaglutide at $99/month and tirzepatide from $159/month at any dose, which is among the lowest advertised pricing we track. Gimme Care advertises tirzepatide at $163/month flat with no membership fees.

Are compounded GLP-1s FDA-approved?

No. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing. This is their defined legal status.

What is the difference between a 503A and 503B pharmacy?

A 503B outsourcing facility registers with the FDA, must follow current good manufacturing practice standards, and is subject to routine FDA inspection. A 503A pharmacy compounds against individual prescriptions and is not held to those manufacturing standards or routine federal inspection. Ask which one dispenses your medication.

Why is flat-dose pricing important for compounded providers?

Because most channels charge more as you titrate. A provider charging the same at 2.5 mg and 10 mg can save several hundred dollars a month against tiered pricing at a maintenance dose — which is where you will spend most of your treatment.

Is compounded medication still worth it now that manufacturers sell direct?

Less than it was. Manufacturer self-pay at $349–$699 has narrowed a gap that used to run against $1,000-plus list prices. Compounded programmes are still cheaper, but the premium for FDA-approved product is now much smaller than it was in 2024.

What should I ask before choosing a compounded provider?

Which pharmacy dispenses it, whether that pharmacy is 503A or 503B, whether you receive a pre-filled syringe or a vial you draw yourself, the exact dose in milligrams and volume, and the beyond-use date.

Bottom Line

The compounded segment is where GLP-1 therapy became affordable for people who could not otherwise access it, and the flat-price providers have pushed that further — $99 semaglutide and $159–$163 tirzepatide at any dose is genuinely transformative pricing.

But the product is not FDA-approved, quality varies by pharmacy, and the gap against approved medication has narrowed sharply. Choose on pharmacy credentials first and price second, ask the five questions above, and check whether insurance or an employer programme makes the whole question moot.

CoreAge Rx: one all-in monthly price from $179–$399 including medication, unlimited provider messaging, and titration support. 12–24 hour approvals. Save up to $200 on your first three months.

Medical disclaimer: Informational only, not medical advice. GLP-1 receptor agonists are prescription medicines with real risks and contraindications. Compounded medications are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality before marketing. Consult a qualified healthcare professional before starting or changing treatment.

Sources: Provider published pricing pages as cited in the linked reviews; independent GLP-1 provider price trackers; FDA guidance on human drug compounding and cautions regarding compounded GLP-1 products.

Date reviewed: August 2026